Wed, Jul 23, 2014, 9:25 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Sunshine Heart Inc. Message Board

  • ex14142000 ex14142000 Aug 7, 2013 5:42 PM Flag

    My guess: another private placement of 3 million shares late in 4th qtr to fund

    operations through 14 at say 15.00 or 17.00 which will be fine with me

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I guess you didn't listen to the call. They have enough cash to take them into the 2nd half of 2014. I don't disagree with you that we could see a last secondary if the stock was $15-$17. However, if they could raise 45-50 mil that should take them to FDA approval. Don't forget they will start to get EU revenues next year. I don't expect huge numbers out of the EU but they will help.

      Sentiment: Strong Buy

      • 2 Replies to sp0rtakus
      • did listen they have 21 mil in cash. There are hiring a number of rather high priced professionals to monitor ... you now how budgets can go in this area. Am stopping by Ohio State to see if I can talk to 'boots' on the gournd. :)

      • Don't mean to sound snarky but it's worth reiterating biotech investing rule #1: Management lies, always.

        But your main point is valid. With some revenue and more institutional investment it will stabilize the share base and provide a lift for higher pps. Then ATM or secondaries can be managed at much higher prices/lower dilution. Macro sentiment is important too.

        Sentiment: Buy

4.80-0.11(-2.24%)Jul 23 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Gilead Sciences Inc.
NasdaqGSWed, Jul 23, 2014 3:59 PM EDT